Former Fusion CFO Crowley joins Centessa

Days after the completion of the takeout of his prior company, Fusion Pharmaceuticals Inc., John Crowley has become CFO of  Centessa Pharmaceuticals plc (NASDAQ:CNTA). He succeeds Gregory Weinhoff, who takes on the newly created role of CBO. Crowley was CFO of Fusion until its $2 billion acquisition by AstraZeneca plc (LSE:AZN; NASDAQ:AZN). 

Medicxi led the launch of Centessa with $250 million in February 2021 to take asset-centric companies further. The biotech, which is led by CEO Saurabh Saha, went public three months later in a $380 million IPO...